From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Dr. Martens – “all key metrics either ahead of, or in line with, last year”. Er, profit and cash generation not key metrics then?!

By Steve Moore | Thursday 1 June 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Previously writing on footwear brand Dr. Martens (DOCS), in April with the shares up towards 155p I noted CFO ‘retires’ & trading warning but CEO Kenny Wilson reckons he looks forward to sharing more details at the full year results! and concluded that it remained a 2021 IPO Roll-Call of Shame avoid/sell. The shares most recently closed at 156.3p… but are currently heading towards 140p on the back of the results Kenny Wilson reckoned he was looking forward to sharing more details at!

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Ariana – Surprise!

Time left: 21:30:05